Advertisement
Screener

Genmab A/S (GMAB) Graph

GMAB Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2025-06-30: Research and development $364.00M; Selling, general and administrative $144.00M.
  • 2024-06-30: Research and development $361.00M; Selling, general and administrative $129.00M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endResearch and developmentSelling, general and administrative
2025-06-30$364.00M$144.00M
2024-06-30$361.00M$129.00M

Revenue and expense 6 month

Period endResearch and developmentSelling, general and administrative
2025-06-30$723.00M$270.00M
2024-06-30$696.00M$243.00M

Revenue and expense 12 month

Period endResearch and developmentSelling, general and administrative
2025-12-31$1.61B$626.00M
2024-12-31$1.41B$549.00M
2023-12-31$1.11B$478.00M